Hong Kong stocks of innovative drug concept stocks fell collectively, Zaiding Pharmaceutical (09688.HK) fell more than 11%, Hengrui Pharmaceutical (01276.HK), Goree Pharmaceutical (01672.HK), Genting Xinyao (01952.HK) fell more than 5%, WuXi AppTec (02359.HK) fell more than 4%, Cinda Biological (01801.HK), WuXi Ming United (02268.HK), Hansen Pharmaceutical (03692.HK) fell more than 3%.
港股创新药概念股集体下跌,再鼎医药(09688.HK)跌超11%,恒瑞医药(01276.HK)、歌礼制药(01672.HK)、云顶新耀(01952.HK)跌超5%,药明康德(02359.HK)跌超4%,信达生物(01801.HK)、药明合联(02268.HK)、翰森制药(03692.HK)跌超3%。
Hong Kong stocks opened, the Hang Seng Index rose 0.20%, the Hang Seng Technology Index fell 0.03%; the concept of innovative drugs collectively opened high, Hengrui Pharmaceutical (01276.HK) rose more than 1%; stablecoin stocks rose sharply, ZhongAn Online (06060.HK) rose more than 6%; building materials cement stocks rebounded, new energy vehicle companies opened low.
Hong Kong stocks closed, the Hang Seng index closed up 0.68%, the index closed down 0.24%. Hengrui medicine (01276.HK) closed up 24.54%, Ningde era (03750.HK) closed up 6.24%.
Hong Kong stocks opened, the Hang Seng Index rose 0.2%, the index rose 0.37%. Most of the innovative drug sector opened higher, Hengrui Pharmaceutical (01276.HK) rose 10.65%, China Biopharmaceutical (01177.HK) rose 2.36%.
Hengrui Pharmaceutical (01276.HK) rose more than 14% in midday trading, and the company's SHR-2173 injection was approved for clinical use.
Hengrui Pharmaceutical (01276.HK) rose more than 18% intraday, the share price exceeded 70 Hong Kong dollars, a record high, the company SHR-2173 injection was approved for clinical, as of now, SHR-2173 injection related projects accumulated research and development investment of about 64.07 million yuan.